Drug
Ly3016859 Isa
Ly3016859 Isa: highest development phase Phase 2, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| LY3016859 ISA NCT05986292 | Phase 2 | Osteoarthritis, Knee |
Latest
No recent events.
Follow Ly3016859 Isa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.